2020
DOI: 10.1136/bmj.m3873
|View full text |Cite
|
Sign up to set email alerts
|

Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases

Abstract: Objective To assess the risks of breast cancer associated with different types and durations of hormone replacement therapy (HRT). Design Two nested case-control studies. Setting UK general practices contributing to QResearch or Clinical Practice Research Datalink (CPRD), linked to hospital, mortality, social deprivation, and cancer registry (QResearch only) data. Participan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
107
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 148 publications
(116 citation statements)
references
References 31 publications
7
107
0
2
Order By: Relevance
“…There are two types of oestrogen (conjugated equine oestrogen and oestradiol) and four types of progestogen (norethisterone acetate, levonorgestrel, medroxyprogesterone, and dydrogesterone) commonly prescribed in the UK. 83 …”
Section: Resultsmentioning
confidence: 99%
“…There are two types of oestrogen (conjugated equine oestrogen and oestradiol) and four types of progestogen (norethisterone acetate, levonorgestrel, medroxyprogesterone, and dydrogesterone) commonly prescribed in the UK. 83 …”
Section: Resultsmentioning
confidence: 99%
“…Estrogen also has an essential effect on the immune function of monocytes and macrophages, and it can inhibit the infiltration of macrophages during the process of AS (Calippe et al, 2010). However, hormone replacement therapy in postmenopausal women caused several adverse effects (Vinogradova et al, 2020;Szabo et al, 2021). Thus, there is an urgent need for us to find some safe estrogen-like drugs.…”
Section: Introductionmentioning
confidence: 99%
“…Reproductive endocrinology colleagues report similar behind-the-scenes interactions prior to the recent metanalysis about hormone replacement therapy (HRT) which put the breast cancer risk of HRT in an interesting perspective (Vinogradova et al, 2020). After the WHI-study from 2002 which widely discredited HRT was shown more than 10 years later to have been severely mispresented at the time, the ideological nature of a fight about very small risks has become obvious.…”
Section: Editorialmentioning
confidence: 99%